The IDF SEA region includes seven countries and territories, each with unique socioeconomic and healthcare challenges. However, one common thread is the rising diabetes impact.
> Read more

From revelations in treatment options to the likelihood of inheriting type 1 diabetes, the presentations at EASD 2024 will potentially shape the future of diabetes management and prevention.
> Read more

Studies presented at ADA showcase new treatment options for type 2 diabetes and weight management for obesity.
> Read more

Research presented highlights the benefits of CGM metrics in predicting the progression and risk of the condition.
> Read more

Position statement presents the 1-hour post-load plasma glucose (1-h PG) test as a more sensitive and practical method to screen for IH and type 2 diabetes in people at risk.
> Read more

The annual European Association for the Study of Diabetes (EASD) conference in Hamburg on 2-6 October brought together global experts to share findings in diabetes research.
> Read more

Clinical trial findings for new survodutide and semaglutide treatments and promising phase 2 retatrutide results.
> Read more

Updates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
> Read more

Heart failure and chronic kidney disease are the first and most frequent manifestations of cardiovascular disease in people with type 2 diabetes and are also associated with increased morbidity and...
> Read more

First-of-its-kind data simulation tool measures the human and public health impact of type 1 diabetes in every country across the globe.
> Read more

IDF launches awareness campaign highlighting the need for improved access to reliable diabetes education for people living with diabetes and healthcare professionals.
> Read more

A documentary film that follows a groundbreaking clinical trial, showing the passion and sacrifice behind every breakthrough cure.
> Read more

New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes.
> Read more

Online study aims to better understand the impact of low blood glucose on the quality of life of people with diabetes and their loved ones.
> Read more

A new publication from the NCD Alliance explains the commonalities in needs and challenges across the different NCD conditions.
> Read more

A key focus of INNODIA is conducting clinical intervention studies to facilitate the development of novel treatments to prevent and cure type 1 diabetes.
> Read more

MoU signed to improve access to affordable and high-quality medicines in low- and middle-income countries.
> Read more

IDF is looking for new data sources of diabetes prevalence to generate national, regional and global estimates.
> Read more

The IDF North American Region spans 29 countries and territories and is home to 48 million people with diabetes. COVID-19 has impacted the region in many ways.
> Read more

The IDF European Region spans 44 countries and territories and is home to 59 million people with diabetes. COVID-19 has impacted the region in many ways.
> Read more

The IDF South and Central America Region spans 20 countries and territories and is home to over 31 million people with diabetes. COVID-19 has impacted the region in many ways.
> Read more

The IDF South-East Asia Region is home to over 87 million people with diabetes. COVID-19 has impacted the region in many ways.
> Read more

The lockdown in Sri Lanka has disrupted access to insulin for people with type 1 diabetes. Young volunteers have led the response to help those in need.
> Read more

The COVID-19 outbreak has been declared an international public health emergency. People with diabetes may be more vulnerable to the severe effects of the virus.
> Read more

Honorary President of IDF dedicated his life to raising diabetes awareness and training health professionals
> Read more

RECOGNISED will explore the biological pathways that may link the alterations observed in the retina with those present in the brain in people with type 2 diabetes.
> Read more

Researchers from the University of Utah Health conducted an online survey focused on different types of underground exchange activities for insulin and other diabetes supplies.
> Read more

A recent study suggests that sleeping less increases risks for type 2 diabetes, cancer, and early death, especially when total sleep equates to less than 6 hours.
> Read more

New approval will help reduce risks associated with kidney disease.
> Read more

UN Member States have committed to advance towards UHC by investing in four major areas.
> Read more

New research suggests that a vegan diet provides improvements in body weight, body composition and blood glucose management.
> Read more

Novo Nordisk will offer a generic and a discount cash card.
> Read more

New study results suggest that findings have the potential to serve as a target for immunotherapy in type 1 diabetes.
> Read more

A number of key disparities and challenges exist for people with diabetes.
> Read more

According to the research, risk can be reduced by at least 23%.
> Read more

Findings from a new study suggest that women with diabetes are at a greater risk for heart failure than men with the condition.
> Read more

US Presidential Candidate Bernie Sanders will join an organised caravan to Canada to purchase affordable insulin along with people living with type 1 diabetes in need.
> Read more

Food insecurity can lead to higher insulin resistance, insulin, glucose, stress hormones, inflammation and total cholesterol.
> Read more

A study found that people who are prescribed statins have at least double the risk of developing type 2 diabetes than those who don’t take the drug.
> Read more

Two published studies report presence of female sexual dysfunction (FSD) in women with type 1 diabetes (T1D).
> Read more

The 79th Scientific Sessions of the American Diabetes Association (ADA) was held on June 7-11, 2019 in San Francisco, USA.
> Read more

Improvements in diabetes-related knowledge and behaviors, but significant gaps remain in self-management care.
> Read more

The FDA issued a stern warning about do-it-yourself artificial pancreas systems after a person with diabetes suffered an insulin overdose.
> Read more

Faster insulins facilitate the rapid movement of insulin through the capillaries into the blood, leading to improved glucose results. Are they worth it?
> Read more

A Touch of Sugar, narrated by Viola Davis, premiered at the Tribeca Film Festival on Thursday, April 25
> Read more

The experience of a diabetes camp through the eyes of a doctor watching a diverse group of youth with type 1 diabetes in the Maldives.
> Read more

US Congress Oversight and Investigations Subcommittee holds second hearing on the insulin pricing crisis in the US.
> Read more

JDRF International Board of Directors unanimously approves the appointment of Aaron J. Kowalski, Ph.D., to serve as its new President and CEO.
> Read more

United States House Committee on Energy & Commerce Oversight and Investigations Subcommittee has hearing on rising cost of insulin.
> Read more

Leaders of the American Academy of Pediatrics (AAP) (USA) have called for insulin affordability to be an urgent priority for the organization in 2019.
> Read more

The SGLT2 class for use by people with type 1 diabetes is under scrutiny, but the EU has approved one, marking the first oral for type 1 diabetes in the...
> Read more

"Hot topics" include technology in all its forms, such as artificial intelligence, mHealth, apps, big data, wearable devices, and tools for diabetes management and monitoring.
> Read more

Cancer awareness and understanding risks are not only important to the general public, but especially for people with diabetes.
> Read more

FDA to decide on approval of use of SGLT1/SGLT2 inhibitors in combination with insulin therapy.
> Read more

By 2030, 79 million people with type 2 diabetes will require insulin to treat the disease, but only half will have access.
> Read more

Marion Nestle helps us understand how food and product studies are more about marketing than science.
> Read more

The Human Trial The story of a biotech start-up on the verge of a major medical breakthrough — a clinical trial that could lead to a cure for type 1 diabetes.
> Read more

International Diabetes Federation regrets lack of ambition in UN HLM Political Declaration.
> Read more

Leaders in type 1 diabetes research and treatment teach students who live with diabetes.
> Read more

In Hong Kong, the annual Hike for Youth Diabetes marks World Diabetes Day and emphasizes the importance of a healthy lifestyle.
> Read more

The IDF European Region organised a week-long series of high-level advocacy activities in Brussels and Strasbourg to mark World Diabetes Day 2018.
> Read more

The IDF Middle East and North Africa Region (MENA) organised a variety of activities focusing on the family for World Diabetes Day and diabetes awareness month.
> Read more

An image gallery of awareness activities organised in the IDF South and Central America (SACA) region for diabetes awareness month and World Diabetes Day 2018.
> Read more

A wide discrepancy is found in the availability and affordability of essential diabetes medicines across the world.
> Read more

New research finds that people with people with prediabetes and undiagnosed diabetes are more likely to be food insecure.
> Read more

About 36 million people around the world are blind. Eye Care Everywhere is the theme of World Sight Day 2018 on October 11.
> Read more

Looking for a simple, flexible, effective way to mark World Diabetes Day 2018? Organise a Global Diabetes Walk!
> Read more

People with diabetes in the US are being advised to get vaccinated before flu season starts.
> Read more

Former IDF representative for the South and Central America Region passed away in August.
> Read more

World Heart Day 2018 on September 29 focuses on looking after our own hearts, and the hearts of our loved ones.
> Read more

Current diabetes screening criteria in the USA that use age and weight alone may miss up to half of prediabetes and diabetes cases, according to a new study published in...
> Read more

IDF estimates that four million people living with diabetes are forcibly displaced as a result of man-made and natural disasters. In these difficult circumstances, people with diabetes often struggle to...
> Read more

People with type 2 diabetes treated with the newer generation of long-acting insulin analogs did not have substantially better outcomes than those treated with less costly human insulin.
> Read more

Data collection for Taking Diabetes to Heart – the International Diabetes Federation’s multi-country study on awareness of cardiovascular disease (CVD) among people with type 2 diabetes came to a close...
> Read more

New research links outdoor air pollution to an increased risk of type 2 diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the...
> Read more

At the 71st World Health Assembly in Geneva in May, IDF presented a multi-stakeholder panel discussion “Nutrition education and IDF action to tackle obesity and prevent diabetes.”
> Read more

Until early 2018, Brazil did not have a regulatory instrument that required standardization of blood glucose meter accuracy. A new standard has been published.
> Read more

The International Diabetes Federation is looking for new data sources of diabetes prevalence to include in the IDF Diabetes Atlas 9th Edition, to be published on 14 November 2019.
> Read more

Dr. V. Mohan received the prestigious Harold Rifkin Distinguished International Service in the Cause of Diabetes Award by the American Diabetes Association (ADA).
> Read more

On May 17, IDF and the Belgian Red Cross Flanders (BRC-F) organized a special session entitled, Where Education Meets Health: Health Education for Children and Adolescents at the Health and...
> Read more

The diabetes youth leadership camp (YLC) is one of the pillar activities of the IDF European Region.
> Read more

Following social media outcry, the Brazilian Ministry of Health is discussing final steps with the National Committee for Health Technology to make rapid-acting analog insulin available for people with type...
> Read more

Education is the driving force to achieve proper management of diabetes. The IDF North American and Caribbean (NAC) Region is prioritizing education and has developed their diabetes education programs to...
> Read more

The IDF Middle East and North America (MENA) region is a diverse and unique territory with great ethical and cultural differences and socio-economic extremes.
> Read more

The IDF European (EU) Region is a wonderful example of unity in diversity – different cultures, healthcare systems, different levels of resources.
> Read more

Diabetes concerns every family is the theme chosen by the International Diabetes Federation.
> Read more